- Home
- PLRX vs BMGL Comparison
PLRX vs BMGL Comparison
Compare PLRX & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- BMGL
- Stock Information
- Founded
- PLRX 2015
- BMGL 2001
- Country
- PLRX United States
- BMGL Singapore
- Employees
- PLRX N/A
- BMGL N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- BMGL
- Sector
- PLRX Health Care
- BMGL
- Exchange
- PLRX Nasdaq
- BMGL NYSE
- Market Cap
- PLRX 84.7M
- BMGL 78.3M
- IPO Year
- PLRX 2020
- BMGL 2025
- Fundamental
- Price
- PLRX $1.60
- BMGL $5.09
- Analyst Decision
- PLRX Hold
- BMGL
- Analyst Count
- PLRX 10
- BMGL 0
- Target Price
- PLRX $9.79
- BMGL N/A
- AVG Volume (30 Days)
- PLRX 1.1M
- BMGL 15.7M
- Earning Date
- PLRX 05-08-2025
- BMGL 01-01-0001
- Dividend Yield
- PLRX N/A
- BMGL N/A
- EPS Growth
- PLRX N/A
- BMGL 16.23
- EPS
- PLRX N/A
- BMGL 0.09
- Revenue
- PLRX N/A
- BMGL $7,428,776.00
- Revenue This Year
- PLRX N/A
- BMGL N/A
- Revenue Next Year
- PLRX N/A
- BMGL N/A
- P/E Ratio
- PLRX N/A
- BMGL $41.66
- Revenue Growth
- PLRX N/A
- BMGL 3.32
- 52 Week Low
- PLRX $1.10
- BMGL $0.91
- 52 Week High
- PLRX $16.10
- BMGL $9.40
- Technical
- Relative Strength Index (RSI)
- PLRX 54.06
- BMGL N/A
- Support Level
- PLRX $1.22
- BMGL N/A
- Resistance Level
- PLRX $1.41
- BMGL N/A
- Average True Range (ATR)
- PLRX 0.09
- BMGL 0.00
- MACD
- PLRX 0.03
- BMGL 0.00
- Stochastic Oscillator
- PLRX 98.21
- BMGL 0.00
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.